Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Open, Classified

Luscient Diagnostics 2nd Generation of COVID-19 Viral Antigen Test For all mutant variety Cat: I-114(Nasal Swab Test)

FDA Recall Z-0717-2022 · Posted None

Recall StatusOpen, Classified
Product CodeQKP
Date Initiated2022-01-13
Product Quantity90,849 kits

Reason for Recall

COVID-19 test kits (Antibody Rapid Test kit and Antigen Rapid Test Kit) are not authorized, cleared, or approved for marketing and/or distribution in the U.S.

Firm Action

On 01/13 and 24/2022, the firm sent an "URGENT MEDICAL DEVICE RECALL" Letter via certified US Mail to customer informing them that the COVID-19 Antigen Tests (Nasal/Saliva) and COVID-19 IgG/IgM Antibody Tests are being recalled because these tests have not received FDA Emergency Use Authorization, nor have these test been cleared or approved by FDA for commercial distribution. Therefore, these tests cannot be legally marketed or distributed in the U.S., nor can they be legally exported from the U.S.. Because the abovementioned products were not authorized, cleared, or approved by FDA, the performance characteristics of these tests have not been adequately established, might presenting a high risk of false positive and false negative results. Customers are instructed to: 1. Immediately discontinue to use these tests. 2. If your firm has distributed these products, immediately provide all consignees with a copy of this recall notification. 3. Discard or destroy all COVID-19 tests manufactured or distributed by LuSys Laboratories, Inc., a.k.a. Luscient Diagnostics LLC, or return the tests to the following address: 7220 Trade Street, Suite 338, San Diego, CA, 92121, before January 30, 2022. For further questions regarding this Recall: -Call Telephone Number - 858-733-2128, or -email [email protected]

Root Cause

No Marketing Application

Distribution Pattern

Worldwide - US Nationwide distribution in the states of CA, NC, NV, OH, TN and TX. The countries of Canada, China, and Mexico. Pending additional information for a complete Consignee Listing

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑